GLYCOMIMETICS INC (GLYC) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Glycomimetics Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Glycomimetics Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$467 M, a 8.67% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$467 M -$37.3 M -8.67% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$456 M -$36.9 M -8.79% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$447 M -$38.1 M -9.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$438 M -$37.4 M -9.33% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$430 M -$42.4 M -10.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 -$420 M -$46.7 M -12.5% Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$409 M -$53.9 M -15.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$401 M -$62.7 M -18.5% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 -$388 M -$63.8 M -19.7% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 -$373 M -$63.4 M -20.5% Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$355 M -$61.6 M -20.9% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 -$338 M -$58 M -20.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$324 M -$57.6 M -21.7% Mar 31, 2021 10-Q 2021-05-03
Q4 2020 -$309 M -$51 M -19.7% Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$294 M -$50.2 M -20.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 -$280 M -$49.7 M -21.6% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 -$266 M -$51.5 M -24% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 -$258 M -$57.9 M -28.9% Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$244 M -$57.1 M -30.6% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 -$230 M -$55.4 M -31.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 -$215 M -$50.8 M -31% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 -$201 M -$48.3 M -31.7% Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$187 M -$43.6 M -30.5% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 -$175 M -$40 M -29.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$164 M -$36.9 M -29% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 -$152 M -$33.3 M -28% Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$143 M -$32.4 M -29.3% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$135 M -$32.3 M -31.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$127 M -$32.2 M -34% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 -$119 M -$31.8 M -36.5% Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$111 M -$32.4 M -41.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 -$103 M -$31.7 M -44.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$94.7 M -$13.2 M -16.2% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 -$87.2 M -$12.8 M -17.2% Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$78.3 M -$11.3 M -16.8% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$71.1 M -$10.7 M -17.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 -$81.5 M Mar 31, 2015 10-Q 2015-05-05
Q4 2014 -$74.4 M -$11.1 M -17.6% Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$67 M Sep 30, 2014 10-Q 2014-10-31
Q2 2014 -$60.4 M Jun 30, 2014 10-Q 2014-07-31
Q4 2013 -$63.3 M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.